Hitt M - Search Results

1

IL-12 gene therapy protects mice in lethal Klebsiella pneumonia.

Greenberger MJ, Kunkel SL, Strieter RM, Lukacs NW, Bramson J, Gauldie J, Graham FL, Hitt M, Danforth JM, Standiford TJ. Greenberger MJ, et al. Among authors: hitt m. J Immunol. 1996 Oct 1;157(7):3006-12. J Immunol. 1996. PMID: 8816409

2

Transient gene transfer of IL-12 regulates chemokine expression and disease severity in experimental arthritis.

Parks E, Strieter RM, Lukacs NW, Gauldie J, Hitt M, Graham FL, Kunkel SL. Parks E, et al. Among authors: hitt m. J Immunol. 1998 May 1;160(9):4615-9. J Immunol. 1998. PMID: 9574569

3

Tumour therapy in mice using adenovirus vectors expressing human TNFa.

Marr RA, Hitt M, Muller WJ, Gauldie J, Graham FL. Marr RA, et al. Among authors: hitt m. Int J Oncol. 1998 Mar;12(3):509-15. doi: 10.3892/ijo.12.3.509. Int J Oncol. 1998. PMID: 9472086

4

A single intramuscular injection with an adenovirus-expressing IL-12 protects BALB/c mice against Leishmania major infection, while treatment with an IL-4-expressing vector increases disease susceptibility in B10.D2 mice.

Gabaglia CR, Pedersen B, Hitt M, Burdin N, Sercarz EE, Graham FL, Gauldie J, Braciak TA. Gabaglia CR, et al. Among authors: hitt m. J Immunol. 1999 Jan 15;162(2):753-60. J Immunol. 1999. PMID: 9916695

5

Gene vectors for cytokine expression in vivo.

Hitt MM, Gauldie J. Hitt MM, et al. Curr Pharm Des. 2000 Apr;6(6):613-32. doi: 10.2174/1381612003400551. Curr Pharm Des. 2000. PMID: 10788600 Review.

6

Adenovirus vectors for human gene therapy.

Hitt MM, Graham FL. Hitt MM, et al. Adv Virus Res. 2000;55:479-505. doi: 10.1016/s0065-3527(00)55014-3. Adv Virus Res. 2000. PMID: 11050953 Review. No abstract available.

7

Construction of a double recombinant adenovirus vector expressing a heterodimeric cytokine: in vitro and in vivo production of biologically active interleukin-12.

Bramson J, Hitt M, Gallichan WS, Rosenthal KL, Gauldie J, Graham FL. Bramson J, et al. Among authors: hitt m. Hum Gene Ther. 1996 Feb 10;7(3):333-42. doi: 10.1089/hum.1996.7.3-333. Hum Gene Ther. 1996. PMID: 8835220

8

Direct intratumoral injection of an adenovirus expressing interleukin-12 induces regression and long-lasting immunity that is associated with highly localized expression of interleukin-12.

Bramson JL, Hitt M, Addison CL, Muller WJ, Gauldie J, Graham FL. Bramson JL, et al. Among authors: hitt m. Hum Gene Ther. 1996 Oct 20;7(16):1995-2002. doi: 10.1089/hum.1996.7.16-1995. Hum Gene Ther. 1996. PMID: 8930660

9

Pre-existing immunity to adenovirus does not prevent tumor regression following intratumoral administration of a vector expressing IL-12 but inhibits virus dissemination.

Bramson JL, Hitt M, Gauldie J, Graham FL. Bramson JL, et al. Among authors: hitt m. Gene Ther. 1997 Oct;4(10):1069-76. doi: 10.1038/sj.gt.3300508. Gene Ther. 1997. PMID: 9415313

10

Combined treatment of a murine breast cancer model with type 5 adenovirus vectors expressing murine angiostatin and IL-12: a role for combined anti-angiogenesis and immunotherapy.

Gyorffy S, Palmer K, Podor TJ, Hitt M, Gauldie J. Gyorffy S, et al. Among authors: hitt m. J Immunol. 2001 May 15;166(10):6212-7. doi: 10.4049/jimmunol.166.10.6212. J Immunol. 2001. PMID: 11342643

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

105 results

Search Page

Filters